bioMérieux S.A. (OTCPK:BMXXY) Q2 2025 Earnings Call September 4, 2025 8:00 AM EDT
Company Participants
Aymeric Fichet
Pierre Boulud – Chief Executive Officer
Guillaume Bouhours – Executive VP of Purchasing and Information Systems & CFO
Conference Call Participants
Anchal Verma – JPMorgan Chase & Co, Research Division
Kavya Deshpande – UBS Investment Bank, Research Division
Maja Pataki – Kepler Cheuvreux, Research Division
Jan Koch – Deutsche Bank AG, Research Division
Natalia Webster – RBC Capital Markets, Research Division
Presentation
Operator
Welcome to the bioMérieux H1 2025 Financial Performance Call. Please note this webcast is being recorded. [Operator Instructions] I will now hand the conference over to Aymeric Fichet, Head of Investor Relations.
Aymeric Fichet
Hello, everyone. Good afternoon, and thank you for joining this call. I’m in line with Pierre Boulud, CEO; together with Guillaume Bouhours, CFO. Please note that this conference call will include forward-looking statements that may change or be modified due to uncertainties and risks related to the company’s environment.
Accordingly, we cannot give any assurance as to whether we will achieve this objective. I also remind you that today’s call is being recorded and that a replay will be available on our website, www.biomerieux-finance.com. I will now hand the call over to Pierre, and then we will open the call to discussions and questions. Pierre?
Pierre Boulud
Chief Executive Officer
Hello, everyone. Good morning, good afternoon. So I’m going to share with you, first of all, key highlights for this first half of the year, and then I’ll follow up with business highlights. Then I will hand over to Guillaume, who will share with you an extensive update on the financial performance. And then I will– he will hand over to me to discuss about the guidance that we’ve issued for the full year 2025, and we’ll open for Q&A.
#BioMérieux #S.A #BMXXY #Earnings #Call #Transcript